Associated Papers
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.
Riedhammer C et al.
Leukemia, 2026
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.
Lee H et al.
Nature Medicine, 2026
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Emde-Rajaratnam M et al.
Frontiers in Immunology, 2023
Select a paper to view details